PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: GlaxoSmithKline
GSK Goes DTC for London Olympics
It’s an unusual sight in the UK — a television commercial for a Big Pharma company. But among the cultural and commercial innovations being attributed to the London Olympic Games is GSK’s first UK consumer-facing corporate brand campaign, showcasing its anti-doping operations. The TV ad debuted on July 16; this week, the company’s campaign went [...]
Posted in Advertising, Europe, Global Also tagged Advertising, advertising campaign, GSK, London 2012, Olympics 2 Comments
Comply or Die: Introducing GSK's New Corporate Integrity Agreement
Big pharma talks a lot about the changing business model and placing a new emphasis on patients, but the fact remains that quantity of medicines sold, not quality of care provided, is how to get paid (and how to keep investors happy). Despite its egalitarian trappings, the healthcare “ecosystem” is still dominated by the [...]
Posted in Agency Insight, Corporate Responsibility, Legal, Marketing, Regulatory, Sales, Strategy, compliance Also tagged CIA, Corporate Integrity Agreement, DoJ, False Claims, fraud, GSK, HHS, Justice Department, Office of Inspector General, OIG Leave a comment
GSK: A Rebuffed Suitor for the Moment
By Patricia Van Arnum.
Last week Human Genome Sciences (HGS) rejected GlaxoSmithKline’s (GSK) unsolicited $2.59 billion bid for HGS or $13 per share. Although rejecting GSK’s initial bid, HGS kept the door open for other suitors, including again GSK.
HGS has authorized its board of directors to explore strategic alternatives for the company, including a potential sale. [...]
Witty Touts GSK Pipeline in 4th Quarter Review
brightcove.createExperiences();
Posted in Emerging Markets, Europe, Global, News, R&D, Strategy Also tagged financial, GSK, patent expiries, pipeline, R&D, Research Leave a comment
New Non-Profit Alliance of Big Pharma Firms